Multiple methods within a single trial [Regulatives / Guidelines]

posted by wienui  – Germany/Oman, 2019-03-13 19:35 (1171 d 01:12 ago) – Posting: # 20030
Views: 4,075

Dear Ohlbe,

» BE trials in patients are indeed usually multi-centre trials. But multiple clinical sites does not mean there has to be multiple bioanalytical labs (unless the analyte is so unstable the samples cannot even afford to be shipped to a central lab ? I don't have any practical example in mind).
» The one difficulty could be if due to the study duration the lab closes down half-way through the study and a new lab has to be used.

Such multiple clinical trial centers ( for one drug product), you might find them in different cities, ( you could find them even in different countries depending on the presence of the patients for a certain disease, therefore we will not be able to talk about a central lab, which uses the same technology.

I have already dealt with such study conducted for an anti-cancer drug in different CRO's in different cities.

Best regards,


Complete thread:

UA Flag
 Admin contact
22,110 posts in 4,630 threads, 1,567 registered users;
online 15 (0 registered, 15 guests [including 3 identified bots]).
Forum time: Friday 21:48 CEST (Europe/Vienna)

We absolutely must leave room for doubt
or there is no progress and no learning.
There is no learning without having to pose a question.
And a question requires doubt.
People search for certainty.
But there is no certainty.    Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz